Long-term infliximab treatment for refractory type III juvenile pityriasis rubra pilaris

Eur J Dermatol. 2011 Jul-Aug;21(4):599-600. doi: 10.1684/ejd.2011.1325.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / therapeutic use*
  • Dermatologic Agents / administration & dosage
  • Dermatologic Agents / therapeutic use*
  • Female
  • Humans
  • Infliximab
  • Infusions, Intravenous
  • Pityriasis Rubra Pilaris / drug therapy*

Substances

  • Antibodies, Monoclonal
  • Dermatologic Agents
  • Infliximab